Exact Mass: 428.2596

Exact Mass Matches: 428.2596

Found 500 metabolites which its exact mass value is equals to given mass value 428.2596, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Irbesartan

2-butyl-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one

C25H28N6O (428.2324)

Irbesartan is an angiotensin receptor blocker (ARB) used mainly for the treatment of hypertension. It competes with angiotensin II for binding at the AT1 receptor subtype. Unlike ACE inhibitors, ARBs do not have the adverse effect of dry cough. The use of ARBs is pending revision due to findings from several clinical trials suggesting that this class of drugs may be associated with a small increased risk of cancer. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 2774 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].

Primolut depot

Pregn-4-ene-3,20-dione, 17-[(1-oxohexyl)oxy]-

C27H40O4 (428.2926)

CONFIDENCE standard compound; INTERNAL_ID 655; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10390; ORIGINAL_PRECURSOR_SCAN_NO 10389 CONFIDENCE standard compound; INTERNAL_ID 655; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10271; ORIGINAL_PRECURSOR_SCAN_NO 10269 CONFIDENCE standard compound; INTERNAL_ID 655; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10375; ORIGINAL_PRECURSOR_SCAN_NO 10374 CONFIDENCE standard compound; INTERNAL_ID 655; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10383; ORIGINAL_PRECURSOR_SCAN_NO 10381 CONFIDENCE standard compound; INTERNAL_ID 655; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10318; ORIGINAL_PRECURSOR_SCAN_NO 10317 CONFIDENCE standard compound; INTERNAL_ID 655; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10339; ORIGINAL_PRECURSOR_SCAN_NO 10337 D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

Aspidoalbine

Aspidospermidin-17-ol, 19,21-epoxy-15,16-dimethoxy-1-(1-oxopropyl)-

C24H32N2O5 (428.2311)

Nummularine F

C23H32N4O4 (428.2423)

4,4-Diapolycopenedial

(all-E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenedial

C30H36O2 (428.2715)

12-epi-Scalaradial

1,2-Chrysenedicarboxaldehyde,12-(acetyloxy)-1,4,4a,4b,5,6,6a,7,8,9,10,10a,10b,11,12,12a-hexadecahydro-4b,7,7,10a,12a-pentamethyl-,(1R,4aS,4bR,6aS,10aS,10bR,12S,12aS)-

C27H40O4 (428.2926)

Nonaethylene glycol monomethyl ether

C19H40O10 (428.2621)

25-Hydroxyvitamin D3-26,23-lactone

(3R,5R)-5-[(2R)-2-[(1R,3aS,4E,7aR)-4-{2-[(1E,5R)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyl-octahydro-1H-inden-1-yl]propyl]-3-hydroxy-3-methyloxolan-2-one

C27H40O4 (428.2926)

This compound belongs to the family of Sesterterpene Lactones. These are sesterterpenes containing a lactone ring

2-Angeloyl-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one

(1Z)-1-Ethylidene-3-{[(2Z)-2-methylbut-2-enoyl]oxy}-4-methylidene-2-oxo-7-(propan-2-yl)-octahydro-1H-inden-5-yl (2E)-3-methylpent-2-enoic acid

C26H36O5 (428.2563)

2-Angeloyl-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea. 2-Angeloyl-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is a constituent of Tussilago farfara (coltsfoot). Constituent of Tussilago farfara (coltsfoot). 2-Angeloyl-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea.

Spirostane-3,6-dione

5,7,9,13-tetramethyl-5-oxaspiro[oxane-2,6-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-16,19-dione

C27H40O4 (428.2926)

Spirostane-3,6-dione is found in fruits. Spirostane-3,6-dione is isolated from fruits of Solanum torvum (pea eggplant). Isolated from fruits of Solanum torvum (pea eggplant). Spirostane-3,6-dione is found in fruits.

Schidigeragenin B

16-hydroxy-7,9,13-trimethyl-5-methylidene-5-oxaspiro[oxane-2,6-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10-one

C27H40O4 (428.2926)

Schidigeragenin B is found in fruits. Genin from Yucca schidigera (Mojave yucca

[(8R,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate

C27H40O4 (428.2926)

Bedoradrine

2-[[7-[[2-hydroxy-2-[4-hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]amino]-5,6,7,8-tetrahydronaphthalen-2-yl]oxy]-N,N-dimethylacetamide

C24H32N2O5 (428.2311)

Calcifediol lactone

3-hydroxy-5-(2-{4-[2-(5-hydroxy-2-methylidenecyclohexylidene)ethylidene]-7a-methyl-octahydro-1H-inden-1-yl}propyl)-3-methyloxolan-2-one

C27H40O4 (428.2926)

Falipamil

2-(3-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}propyl)-5,6-dimethoxy-2,3-dihydro-1H-isoindol-1-one

C24H32N2O5 (428.2311)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

Lotrafiban

2-(7-{[4,4-bipiperidine]-1-carbonyl}-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-2-yl)acetic acid

C23H32N4O4 (428.2423)

MG(PGF2alpha/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoic acid

C23H40O7 (428.2774)

MG(PGF2alpha/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(PGE1/0:0/0:0)

(2S)-2,3-Dihydroxypropyl 7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoic acid

C23H40O7 (428.2774)

MG(PGE1/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(PGD1/0:0/0:0)

(2S)-2,3-Dihydroxypropyl 7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoic acid

C23H40O7 (428.2774)

MG(PGD1/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(0:0/PGF2alpha/0:0)

1,3-dihydroxypropan-2-yl (5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoate

C23H40O7 (428.2774)

MG(0:0/PGF2alpha/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(0:0/PGE1/0:0)

1,3-Dihydroxypropan-2-yl 7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoic acid

C23H40O7 (428.2774)

MG(0:0/PGE1/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(0:0/PGD1/0:0)

1,3-Dihydroxypropan-2-yl 7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoic acid

C23H40O7 (428.2774)

MG(0:0/PGD1/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

JOKBBQPBIIZMJV-UHFFFAOYSA-N

10aH-2,12a-Methano-1H,4H-cyclopropa(5,6)(1,3)dioxolo(2,3)cyclopenta(1,2:9,10)cyclodeca(1,2-d)(1,3)dioxin-15-one, 1a,2,7a,13,14,14a-hexahydro-1,1,6,6,9,9,11,13-octamethyl-, (1aR-(1aalpha,2alpha,7aalpha,7bR*,10aalpha,12aalpha,13alpha,14aalpha))-

C26H36O5 (428.2563)

Ingenol-3,4,5,20-diacetonide is a natural compound.

3-Oxo-21α-methoxy-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone

(4S,5R)-5-methoxy-4-[(5R,9R,10R,13S,14S,17S)-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]oxolan-2-one

C27H40O4 (428.2926)

Neoruscogenin

(1S,2S,4S,6R,7S,8R,9S,12S,13R,14R,16R)-7,9,13-trimethyl-5-methylidenespiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2-oxane]-14,16-diol

C27H40O4 (428.2926)

Neoruscogenin is a natural product found in Helleborus orientalis with data available. Neoruscogenin, a member of the steroidal sapogenin family, is a bioavailable, potent, and high-affinity agonist of the nuclear receptor RORα (NR1F1)[1]. Neoruscogenin, a member of the steroidal sapogenin family, is a bioavailable, potent, and high-affinity agonist of the nuclear receptor RORα (NR1F1)[1].

Andrastin D

C26H36O5 (428.2563)

A 3-oxo steroid that is andrastin C in which the acetoxy group at the 3beta position has undergone formal oxidative cleavage to afford the corresponding 3-oxo derivative. A farnesyltransferase inhibitor produced by Penicillium roqueforti, a filamentous fungus involved in the ripening of several kinds of blue cheeses. CONFIDENCE Penicillium bissettii

Chabrolohydroxybenzoquinone F

(+)-Chabrolohydroxybenzoquinone F

C27H40O4 (428.2926)

Sargachromanol I

C27H40O4 (428.2926)

CHEMBL221393

C27H40O4 (428.2926)

Graviphane

C26H36O5 (428.2563)

Kuguacin D

C27H40O4 (428.2926)

Schisanterpene B

C27H40O4 (428.2926)

Strongylophorin 8

C26H36O5 (428.2563)

Scalarafuran

C27H40O4 (428.2926)

Isoscalarafuran A

(+)-Isoscalarafuran A

C27H40O4 (428.2926)

Suberitenone C

C27H40O4 (428.2926)

Rhodomollein XI

C22H36O8 (428.241)

13-(6-hydroxy-2,8-dimethyl-3,4-dihydrochromen-2-yl)-2,6,10-trimethyltrideca-2,6,10-triene-4,5-diol

C27H40O4 (428.2926)

Sargachromanol H

C27H40O4 (428.2926)

Rhodomollein XVI

C22H36O8 (428.241)

Dendronpholide J

C22H36O8 (428.241)

Fallahydroquinone

C27H40O4 (428.2926)

Mooloolaldehyde

C27H40O4 (428.2926)

Comnostin A

C27H40O4 (428.2926)

Palauimide

C25H36N2O4 (428.2675)

Aspidospermiose

C24H32N2O5 (428.2311)

25,26,27-Trinor-3,7-dioxolanost-8-en-24-oic acid

C27H40O4 (428.2926)

(+)-Cineverine

13alpha-(3,4-Dimethoxybenzoyl)oxylupanine

C24H32N2O5 (428.2311)

Prostaglandin F2alpha-1-glyceryl ester

C23H40O7 (428.2774)

Sarga tetraol

C27H40O4 (428.2926)

Maurapyrone B

C26H36O5 (428.2563)

Tamusgenin

C27H40O4 (428.2926)

Demethylstriatol|Mono-norstriatol

C27H40O4 (428.2926)

7-Keto-diosgenin

C27H40O4 (428.2926)

Vilasinin

C26H36O5 (428.2563)

(2E,6E)-2-(10(S),11(S)-dihydroxygeranylgeranyl)-6-methyl-1,4-benzoquinone

C27H40O4 (428.2926)

17,18-Dihydro,17-hydroxy-(2,4,6-Trihydroxyphenyl)-5,8,11,14,17-eicosapentaen-1-one,9CI|2-(17-hydroxy-1-oxo-dodeca-5,8,11,14(all Z)-tetraenyl)-1,3,5-trihydroxybenzene|2-[17-hydroxy-1-oxo-dodeca-5,8,11,14(all Z)-tetraenyl]-1,3,5-trihydroxybenzene

17,18-Dihydro,17-hydroxy-(2,4,6-Trihydroxyphenyl)-5,8,11,14,17-eicosapentaen-1-one,9CI|2-(17-hydroxy-1-oxo-dodeca-5,8,11,14(all Z)-tetraenyl)-1,3,5-trihydroxybenzene|2-[17-hydroxy-1-oxo-dodeca-5,8,11,14(all Z)-tetraenyl]-1,3,5-trihydroxybenzene

C26H36O5 (428.2563)

3,6-Dihydroxy-2-(15-phenylpentadecanoyl)-2-cyclohexen-1-one

C27H40O4 (428.2926)

17-Hydroxy-2-(5-Hydoxy-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)-6-methyl-1,2-benzendiol|2-((2E,6E,10E,14Z)-5-hydroxy-15-hydroxymethyl-3,7,11-trimethylhexadeca-2,6,10,14-tetraenyl)-6-methylhydroquinone|2-<(2E,6E,10E,14Z)-5-hydroxy-15-hydroxymethyl-3,7,11-trimethylhexadeca-2,6,10,14-tetraenyl>-6-methylhydroquinone|2-[(2E,6E,10E,14Z)-5-hydroxy-15-hydroxymethyl-3,7,11-trimethylhexadeca-2,6,10,14-tetraenyl]-6-methylhydroquinone

17-Hydroxy-2-(5-Hydoxy-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)-6-methyl-1,2-benzendiol|2-((2E,6E,10E,14Z)-5-hydroxy-15-hydroxymethyl-3,7,11-trimethylhexadeca-2,6,10,14-tetraenyl)-6-methylhydroquinone|2-<(2E,6E,10E,14Z)-5-hydroxy-15-hydroxymethyl-3,7,11-trimethylhexadeca-2,6,10,14-tetraenyl>-6-methylhydroquinone|2-[(2E,6E,10E,14Z)-5-hydroxy-15-hydroxymethyl-3,7,11-trimethylhexadeca-2,6,10,14-tetraenyl]-6-methylhydroquinone

C27H40O4 (428.2926)

spirosta-5,25(27)-dien-1,3-diol

C27H40O4 (428.2926)

kadnanolactone E

C27H40O4 (428.2926)

Stypotriol

C27H40O4 (428.2926)

(25R)-3beta-Hydroxy-5alpha-spirost-9(11)-en-12-on|(25R)-3beta-hydroxy-5alpha-spirost-9(11)-en-12-one|3beta-hydroxy-9(11)-en-12-oxo-(25R)-5alpha-spirostane|9(11)-dehydrohecogenin|9-dehydrohecogenin|Delta9(11)-22-isoallospirosten-3beta-ol-12-one|Delta9(11)-hecogenin

C27H40O4 (428.2926)

Lyoniol D|Lyoniol-D

C22H36O8 (428.241)

scalarolide acetate

C27H40O4 (428.2926)

(25R)-17-Hydroxy-spirost-4-en-3-on|(25R)-17-hydroxy-spirost-4-en-3-one|(25R)-17alpha-hydroxyspirost-4-en-3-one|diosbulbisin A

C27H40O4 (428.2926)

methyl-3alpha-angeloyloxypolyalthoate

C26H36O5 (428.2563)

Tricoccin S13

C26H36O5 (428.2563)

4-O-methyl valdivone A

C26H36O5 (428.2563)

12alpha-(2-methylbutyryloxy)-strictic acid methyl ester|12alpha-<2-methylbutyryloxy>-strictic acid methyl ester

C26H36O5 (428.2563)

Ingenol-3,4:5,20-diacetonide

C26H36O5 (428.2563)

Furospongin 4

C26H36O5 (428.2563)

deoxyscalarin

C27H40O4 (428.2926)

Echinoclathrine C

C25H36N2O2S (428.2497)

C27H40O4

C27H40O4 (428.2926)

12-deacetoxyscalarin 19-acetate

C27H40O4 (428.2926)

3-O-methylfuranovibsanin A

C26H36O5 (428.2563)

capilloquinone

C27H40O4 (428.2926)

Tabascanine

C24H32N2O5 (428.2311)

Litophytolide A

C27H40O4 (428.2926)

Plastoquinone C2

C27H40O4 (428.2926)

4-hydroxy-3-(((1R,4aR,5S,6S,8aR)-6-hydroxy-5,8a-dimethyl-2-methylene-5-(4-methylpent-3-enyl)-decahydronaphthalen-1-yl)-methyl)-5,6-dimethyl-2H-pyran-2-one|BR-050

C27H40O4 (428.2926)

2-((2E,6E)-5-hydroxy-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,14-trienyl)-6-methylhydroquinol|2-<(2E,6E)-5-hydroxy-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,14-trienyl>-6-methylhydroquinol

C27H40O4 (428.2926)

Methyl(20S,22E)-3beta-acetoxychol-5,22-dienat

C27H40O4 (428.2926)

3alpha-hydroxy-11-hydroxy-iso-iphionan-4-one-(alpha-xylopyranoside-2-O-acetate)|3alpha-hydroxy-11-hydroxy-iso-iphionan-4-one-

C22H36O8 (428.241)

salmahyrtisol A

C27H40O4 (428.2926)

(5alpha,12beta,17beta)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-2-methyl-5-oxo-2,5-dihydrofuran-2-yl]gonan-3-one|cylindrictone B

C27H40O4 (428.2926)

19-O-Angeloylhautriwasaeure-methylester

C26H36O5 (428.2563)

(3E,11E)-6,19-epoxy-17,20-dihydroxycembra-3,6,8(19),11,15-pentaene 17-butanoate, 20-acetate

C26H36O5 (428.2563)

19-acetyl-12-deacetoxy-12-oxo-deoxoscalarin

C27H40O4 (428.2926)

4,4,14-trimethyl-3,7,15-trimethyl-3,7-dioxochol-8-en-24-oic acid|4,4,14-trimethyl-3,7-dioxochol-8-en-24-oic acid|4,4,14alpha-trimethyl-3,7-dioxo-5alpha-chol-8-en-24-oic acid

C27H40O4 (428.2926)

20S,24-epoxy-25,26,27-trisnor-24-oxo-3,4-seco-dammar-4(28),22-dien-3-oic acid

C27H40O4 (428.2926)

3-Oxo-21|A-methoxy-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone

C27H40O4 (428.2926)

isofurospongin-4

C26H36O5 (428.2563)

A natural product found in Spongia officinalis.

1alpha-acetoxy-3beta,6,8alpha-trihydroxy-2alpha-methoxy-2beta,14beta-epoxy-[4.2.1.10,301.1,4]-tricyclomeliac-7-oate

C26H36O5 (428.2563)

(2R)-2,8-dimethyl-2-[(3E,7E)-4,8-dimethyl-13-hydroxy-12-hydroxymethyldeca-3,7,11-trienyl]chroman-6-ol|delta-amplexichromanol

C27H40O4 (428.2926)

erythro-23-O-methylneocyclocitrinol|threo-23-O-methylneocyclocitrinol

C27H40O4 (428.2926)

13,14-dihydroxy-15,16 dimethoxy-(-)-6alpha-hydroxy-5alpha,8alpha,9alpha,10alpha-cleroda-3-en-18-oic acid

C22H36O8 (428.241)

calcaripeptide C

C24H32N2O5 (428.2311)

2alpha-(4-methylsenecioyloxy)-15,16-epoxylabda-7,13(16),14-trien-18-oic acid|2alpha-<4-methylsenecioyloxy>-15,16-epoxylabda-7,13(16),14-trien-18-oic acid

C26H36O5 (428.2563)

gutierrezianolic acid (angelate) methyl ester|gutierrezianolic acid methyl ester|methyl 6alpha-angeloyloxy-15,16-epoxy-labda-7,13(16),14-trien-17-oate

C26H36O5 (428.2563)

7alpha,21-dihydroxy-3-oxo-24,25,26,27-tetranorapotirucall-14,20(22)-dien-21,23-olide

C26H36O5 (428.2563)

C26H36O5

C26H36O5 (428.2563)

3,4-dimethoxy-benzoic acid 11-oxo-dodecahydro-7,14-methano-dipyrido[1,2-a;1,2-e][1,5]diazocin-2-yl ester|Cineverin|Cineverin (13-Veratroyloxy-lupanin)

C24H32N2O5 (428.2311)

(3E,11E)-6,19-epoxy-17,20-dihydroxycembra-3,6,8(19),11,15-pentaene 17-acetate, 20-butanoate

C26H36O5 (428.2563)

cladobotric acid B

C26H36O5 (428.2563)

5beta,11-dihydroxy-iphionan-4-one-11-O-(alpha-xylopyranoside-2-O-acetate)|5beta,11-dihydroxy-iphionan-4-one-11-O-

C22H36O8 (428.241)

(+)-dodecanoyllomatin

C26H36O5 (428.2563)

furospongin 4|furospongin-4

C26H36O5 (428.2563)

24-methyl-12,24,25-trioxoscalar-16-en-22-oic acid

C26H36O5 (428.2563)

19-norpregna-1,3,5(10),20-tetraen-3-O-alpha-fucopyranoside

C26H36O5 (428.2563)

Furospongin 3

C26H36O5 (428.2563)

4,5-dioxo-seco-gamma-eudesmol-(alpha-xylopyranoside-2-O-acetate)|4,5-dioxo-seco-gamma-eudesmol-

C22H36O8 (428.241)

Trp Pro Leu

C23H32N4O4 (428.2423)

Leu Pro Trp

C23H32N4O4 (428.2423)

irbesartan

C25H28N6O (428.2324)

C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1074 CONFIDENCE standard compound; INTERNAL_ID 2094 CONFIDENCE standard compound; INTERNAL_ID 8187 Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].

Irbesartan (Avapro)

C25H28N6O (428.2324)

Irbesartan. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=138402-11-6 (retrieved 2024-07-09) (CAS RN: 138402-11-6). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].

Ala Glu Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carboxybutanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C19H32N4O7 (428.2271)

Ala Glu Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carboxybutanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C19H32N4O7 (428.2271)

Ala Glu Pro Ile

(4S)-4-[(2S)-2-aminopropanamido]-5-[(2S)-2-{[(1S,2S)-1-carboxy-2-methylbutyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C19H32N4O7 (428.2271)

Ala Glu Pro Leu

(4S)-4-[(2S)-2-aminopropanamido]-5-[(2S)-2-{[(1S)-1-carboxy-3-methylbutyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C19H32N4O7 (428.2271)

Ala Ile Glu Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C19H32N4O7 (428.2271)

Ala Ile Pro Glu

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C19H32N4O7 (428.2271)

Ala Lys Asn Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C18H32N6O6 (428.2383)

Ala Lys Pro Asn

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C18H32N6O6 (428.2383)

Ala Leu Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C19H32N4O7 (428.2271)

Ala Leu Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C19H32N4O7 (428.2271)

Ala Asn Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C18H32N6O6 (428.2383)

Ala Asn Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C18H32N6O6 (428.2383)

Ala Pro Glu Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-carboxybutanamido]-3-methylpentanoic acid

C19H32N4O7 (428.2271)

Ala Pro Glu Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-carboxybutanamido]-4-methylpentanoic acid

C19H32N4O7 (428.2271)

Ala Pro Ile Glu

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]pentanedioic acid

C19H32N4O7 (428.2271)

Ala Pro Lys Asn

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}hexanamido]-3-carbamoylpropanoic acid

C18H32N6O6 (428.2383)

Ala Pro Leu Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]pentanedioic acid

C19H32N4O7 (428.2271)

Ala Pro Asn Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]hexanoic acid

C18H32N6O6 (428.2383)

Asp Pro Val Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-methylbutanoic acid

C19H32N4O7 (428.2271)

Asp Val Pro Val

(3S)-3-amino-3-{[(2S)-1-[(2S)-2-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamoyl}propanoic acid

C19H32N4O7 (428.2271)

Asp Val Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylbutanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C19H32N4O7 (428.2271)

Glu Ala Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]propanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C19H32N4O7 (428.2271)

Glu Ala Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]propanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C19H32N4O7 (428.2271)

Glu Ala Pro Ile

(4S)-4-amino-4-{[(2S)-1-[(2S)-2-{[(1S,2S)-1-carboxy-2-methylbutyl]carbamoyl}pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}butanoic acid

C19H32N4O7 (428.2271)

Glu Ala Pro Leu

(4S)-4-amino-4-{[(2S)-1-[(2S)-2-{[(1S)-1-carboxy-3-methylbutyl]carbamoyl}pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}butanoic acid

C19H32N4O7 (428.2271)

Glu Ile Ala Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylpentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C19H32N4O7 (428.2271)

Glu Ile Pro Ala

(4S)-4-amino-4-{[(2S,3S)-1-[(2S)-2-{[(1S)-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]carbamoyl}butanoic acid

C19H32N4O7 (428.2271)

Glu Leu Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-methylpentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C19H32N4O7 (428.2271)

Glu Leu Pro Ala

(4S)-4-amino-4-{[(2S)-1-[(2S)-2-{[(1S)-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl}butanoic acid

C19H32N4O7 (428.2271)

Glu Pro Ala Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carboxybutanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-methylpentanoic acid

C19H32N4O7 (428.2271)

Glu Pro Ala Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carboxybutanoyl]pyrrolidin-2-yl]formamido}propanamido]-4-methylpentanoic acid

C19H32N4O7 (428.2271)

Glu Pro Ile Ala

(4S)-4-amino-5-[(2S)-2-{[(1S,2S)-1-{[(1S)-1-carboxyethyl]carbamoyl}-2-methylbutyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C19H32N4O7 (428.2271)

Glu Pro Leu Ala

(4S)-4-amino-5-[(2S)-2-{[(1S)-1-{[(1S)-1-carboxyethyl]carbamoyl}-3-methylbutyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C19H32N4O7 (428.2271)

Gly Lys Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C19H36N6O5 (428.2747)

Gly Lys Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-6-amino-2-(2-aminoacetamido)hexanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C19H36N6O5 (428.2747)

Gly Lys Pro Gln

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-(2-aminoacetamido)hexanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C18H32N6O6 (428.2383)

Gly Lys Gln Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C18H32N6O6 (428.2383)

Gly Pro Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}hexanamido]hexanoic acid

C19H36N6O5 (428.2747)

Gly Pro Lys Gln

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}hexanamido]-4-carbamoylbutanoic acid

C18H32N6O6 (428.2383)

Gly Pro Gln Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]hexanoic acid

C18H32N6O6 (428.2383)

Gly Gln Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C18H32N6O6 (428.2383)

Gly Gln Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C18H32N6O6 (428.2383)

Ile Ala Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C19H32N4O7 (428.2271)

Ile Ala Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C19H32N4O7 (428.2271)

Ile Glu Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-carboxybutanamido]propanoyl]pyrrolidine-2-carboxylic acid

C19H32N4O7 (428.2271)

Ile Glu Pro Ala

(4S)-4-[(2S,3S)-2-amino-3-methylpentanamido]-5-[(2S)-2-{[(1S)-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C19H32N4O7 (428.2271)

Ile Ile Pro Ser

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid